Survivorship/Psychosocial

Lori Brotto

Lori Brotto, PhD

March 17, 2022

Lori Brotto, PhDThe University of British Columbia2022 Maxine & Julie Eisen Pilot Study Award eSense Cancer: Adapting an online intervention for sexual health concerns to ovarian cancer Sexual health concerns are common after treatment of ovarian cancer, yet effective and accessible treatments to manage those concerns are not available. Dr. Brotto’s team has developed an […]

Read More

Melissa Thrall, MD

August 18, 2019

Melissa Thrall, MDUniversity of Washington A population based evaluation of the use and outcomes of neoadjuvant chemotherapy The current standard of care for the treatment of advanced stage ovarian cancer involves surgery with a maximal effort to remove all visible tumor followed by the administration of platinum based chemotherapy. However not all women with advanced […]

Read More

Elizabeth Poole, PhD

August 18, 2019

Elizabeth Poole, PhDBrigham and Women’s Hospital2015 Skacel Family Scholar Medication use and ovarian cancer survival Although factors that contribute to ovarian cancer risk prior to diagnosis are currently being teased apart, factors which contribute to survival after a diagnosis of ovarian cancer have not yet been well studied. Dr. Poole’s project will develop the Nurses’ […]

Read More

Melissa Merritt, PhD

August 18, 2019

Melissa Merritt, PhDUniversity of Hawaii Cancer Center Obesity-related factors and ovarian cancer survival Women diagnosed with ovarian cancer have a poor prognosis, and there are currently no recommendations for lifestyle modifications that may influence survival after a diagnosis. Dr. Merritt will evaluate whether obesity-related factors, including Body Mass Index (BMI), waist circumference, physical activity, and […]

Read More

Heidi Gray, MD

August 17, 2019

Heidi Gray, MDUniversity of Washington Behavioral and neural indices of cognitive rehabilitation in ovarian cancer Millions of ovarian cancer survivors live with residual symptoms of impaired thinking and impaired memory severe enough to interfere with basic activities of daily living and work. However, very little is known about how to treat problems in cognition. Pharmacologic […]

Read More

M. Robyn Andersen, MPH, PhD

August 17, 2019

M. Robyn Andersen, MPH, PhDFred Hutchinson Cancer Research Center 2017 James A. Harting Pilot Study Award RESTART: Learning to reduce stress and anxiety after treatment Many ovarian cancer patients experience distress for years after their diagnosis, even during periods of remission and stable disease. Studies have shown that changes in the nervous system and inflammatory […]

Read More